Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients.
{iframe}http://www.baltimoresun.com/business/bs-bz-pgdx-series-b-20180104-story.html{/iframe}
Personal Genome Diagnostics closes $75 million financing round – Baltimore Sun